COVID-19 Impact on Antibody-drug Conjugate Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Antibody-drug Conjugate Industry
1.7 COVID-19 Impact: Antibody-drug Conjugate Market Trends
2 Global Antibody-drug Conjugate Quarterly Market Size Analysis
2.1 Antibody-drug Conjugate Business Impact Assessment - COVID-19
2.1.1 Global Antibody-drug Conjugate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Antibody-drug Conjugate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Antibody-drug Conjugate Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Antibody-drug Conjugate Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Antibody-drug Conjugate Factory Price by Manufacturers
3.3 Location of Key Manufacturers Antibody-drug Conjugate Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
3.5 Key Manufacturers Antibody-drug Conjugate Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Antibody-drug Conjugate Segments, By Type
4.1 Introduction
1.4.1 Adcetris
1.4.2 Kadcyla
4.2 By Type, Global Antibody-drug Conjugate Market Size, 2019-2021
4.2.1 By Type, Global Antibody-drug Conjugate Market Size by Type, 2020-2021
4.2.2 By Type, Global Antibody-drug Conjugate Price, 2020-2021
5 Impact of Covid-19 on Antibody-drug Conjugate Segments, By Application
5.1 Overview
5.5.1 Breast Cancer
5.5.2 Lymphoma
5.2 By Application, Global Antibody-drug Conjugate Market Size, 2019-2021
5.2.1 By Application, Global Antibody-drug Conjugate Market Size by Application, 2019-2021
5.2.2 By Application, Global Antibody-drug Conjugate Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Agensys
7.1.1 Agensys Business Overview
7.1.2 Agensys Antibody-drug Conjugate Quarterly Production and Revenue, 2020
7.1.3 Agensys Antibody-drug Conjugate Product Introduction
7.1.4 Agensys Response to COVID-19 and Related Developments
7.2 Concortis Biotherapeutics
7.2.1 Concortis Biotherapeutics Business Overview
7.2.2 Concortis Biotherapeutics Antibody-drug Conjugate Quarterly Production and Revenue, 2020
7.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Product Introduction
7.2.4 Concortis Biotherapeutics Response to COVID-19 and Related Developments
7.3 Sanofi
7.3.1 Sanofi Business Overview
7.3.2 Sanofi Antibody-drug Conjugate Quarterly Production and Revenue, 2020
7.3.3 Sanofi Antibody-drug Conjugate Product Introduction
7.3.4 Sanofi Response to COVID-19 and Related Developments
7.4 Celldex Therapeutics
7.4.1 Celldex Therapeutics Business Overview
7.4.2 Celldex Therapeutics Antibody-drug Conjugate Quarterly Production and Revenue, 2020
7.4.3 Celldex Therapeutics Antibody-drug Conjugate Product Introduction
7.4.4 Celldex Therapeutics Response to COVID-19 and Related Developments
7.5 Synthon Holding BV
7.5.1 Synthon Holding BV Business Overview
7.5.2 Synthon Holding BV Antibody-drug Conjugate Quarterly Production and Revenue, 2020
7.5.3 Synthon Holding BV Antibody-drug Conjugate Product Introduction
7.5.4 Synthon Holding BV Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Antibody-drug Conjugate Supply Chain Analysis
8.1.1 Antibody-drug Conjugate Supply Chain Analysis
8.1.2 Covid-19 Impact on Antibody-drug Conjugate Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Antibody-drug Conjugate Distribution Channels
8.2.2 Covid-19 Impact on Antibody-drug Conjugate Distribution Channels
8.2.3 Antibody-drug Conjugate Distributors
8.3 Antibody-drug Conjugate Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Antibody-drug Conjugate Assessment
Table 9. COVID-19 Impact: Antibody-drug Conjugate Market Trends
Table 10. COVID-19 Impact Global Antibody-drug Conjugate Market Size
Table 11. Global Antibody-drug Conjugate Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Antibody-drug Conjugate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Antibody-drug Conjugate Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Antibody-drug Conjugate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Antibody-drug Conjugate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Antibody-drug Conjugate Market Growth Drivers
Table 17. Global Antibody-drug Conjugate Market Restraints
Table 18. Global Antibody-drug Conjugate Market Opportunities
Table 19. Global Antibody-drug Conjugate Market Challenges
Table 20. Key Manufacturers Antibody-drug Conjugate Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Antibody-drug Conjugate Market Size, 2019 (K Units) & (US$ Million)
Table 22. Antibody-drug Conjugate Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Antibody-drug Conjugate Manufacturing Plants
Table 24. Key Manufacturers Antibody-drug Conjugate Market Served
Table 25. Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
Table 26. Key Manufacturers Antibody-drug Conjugate Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Antibody-drug Conjugate Market Size by Type, 2020, (US$ Million)
Table 29. Global Antibody-drug Conjugate Market Size by Type, 2020 (K Units)
Table 30. Global Antibody-drug Conjugate Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Antibody-drug Conjugate Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Antibody-drug Conjugate Market Size by Application, 2020-2021 (K Units)
Table 33. Global Antibody-drug Conjugate Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Antibody-drug Conjugate Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Antibody-drug Conjugate Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Antibody-drug Conjugate Market Size, 2019-2021 (K Units)
Table 38. US Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Antibody-drug Conjugate Market Size, 2019-2021 (K Units)
Table 43. Germany Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Antibody-drug Conjugate Market Size, 2019-2021 (K Units)
Table 50. China Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Antibody-drug Conjugate Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Agensys Business Overview
Table 58. Agensys Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Agensys Antibody-drug Conjugate Product
Table 60. Agensys Response to COVID-19 and Related Developments
Table 61. Concortis Biotherapeutics Business Overview
Table 62. Concortis Biotherapeutics Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Concortis Biotherapeutics Antibody-drug Conjugate Product
Table 64. Concortis Biotherapeutics Response to COVID-19 and Related Developments
Table 65. Sanofi Business Overview
Table 66. Sanofi Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sanofi Antibody-drug Conjugate Product
Table 68. Sanofi Response to COVID-19 and Related Developments
Table 69. Celldex Therapeutics Business Overview
Table 70. Celldex Therapeutics Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Celldex Therapeutics Antibody-drug Conjugate Product
Table 72. Celldex Therapeutics Response to COVID-19 and Related Developments
Table 73. Synthon Holding BV Business Overview
Table 74. Synthon Holding BV Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Synthon Holding BV Antibody-drug Conjugate Product
Table 76. Synthon Holding BV Response to COVID-19 and Related Developments
Table 77. Antibody-drug Conjugate Distributors List
Table 78. Antibody-drug Conjugate Customers List
Table 79. Covid-19 Impact on Antibody-drug Conjugate Customers
List of FiguresFigure 1. Antibody-drug Conjugate Product Picture
Figure 2. Antibody-drug Conjugate Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Antibody-drug Conjugate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Antibody-drug Conjugate Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Antibody-drug Conjugate Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Antibody-drug Conjugate Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Antibody-drug Conjugate Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Antibody-drug Conjugate Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Antibody-drug Conjugate Market Size Market Share, 2019-2021